 |
         
|
Any time a corporation pays a $1.4bn criminal fine for "egregious" marketing abuses it should be headline news. Big Pharma's Eli Lilly has USAirways to thank for its abuses passing largely unnoticed. Only CBS covered the case of Zyprexa, the prescription medication for schizophrenia, that Eli Lilly's sales force was accused of pushing for so-called off-label use. Sharyl Attkisson told us that the antipsychotic drug, whose side effects can include weight gain and diabetes, was sold for "children in foster care, people who have trouble sleeping, elderly in nursing homes." Five at Five was the Zyrexa slogan, meaning 5mg dispensed at 5pm would keep patients quiet.
Eli Lilly: Indy-based pharmaceutical company pleads guilty to promoting Zyprexa for unapproved uses; is slapped with $1.4 billion criminal fine, the largest ever placed on a U.S. company.
Conflict of interest.
Eli Lilly promotes sales of their #1 drug (Zyprexa $4.8 billion year) that can *cause* diabetes and then turn around and make billions selling more drugs to treat the diabetes.
Eli Lilly's # 1 cash cow Zyprexa has been overprescribed and linked to a ten times greater risk of causing type #2 diabetes and increased risk of heart attacks.
Daniel Haszard Zyprexa patient who got the diabetes from it. www.zyprexa-victims.com
You must be logged in to this website to leave a comment. Please click here to log in so you can participate in the discussion.
